Eastern Europe: Market for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in Eastern Europe

For the third consecutive year, the East European market for non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses recorded growth in sales value, which increased by X% to $X in 2023. The total consumption indicated measured growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption decreased by X% against 2019 indices. Over the period under review, the market reached the peak level at $X in 2019; however, from 2020 to 2023, consumption failed to regain momentum.

Production of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses in Eastern Europe

In value terms, production of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses declined slightly to $X in 2023 estimated in export price. The total production indicated a tangible expansion from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven years. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production decreased by X% against 2021 indices. The pace of growth was the most pronounced in 2013 with an increase of X%. The level of production peaked at $X in 2019; however, from 2020 to 2023, production stood at a somewhat lower figure.

Exports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses

Exports in Eastern Europe

After four years of decline, shipments abroad of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses increased by X% to X tons in 2023. Over the period under review, exports saw strong growth. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, the exports of attained the maximum at X tons in 2018; however, from 2019 to 2023, the exports failed to regain momentum.

In value terms, exports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses skyrocketed to $X in 2023. Total exports indicated a resilient increase from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, exports increased by X% against 2021 indices. As a result, the exports attained the peak and are likely to continue growth in the immediate term.

Exports by Country

Poland represented the largest exporting country with an export of around X tons, which finished at X% of total exports. Slovakia (X tons) held a X% share (based on physical terms) of total exports, which put it in second place, followed by the Czech Republic (X%), Russia (X%), Hungary (X%) and Bulgaria (X%). Lithuania (X tons) took a relatively small share of total exports.

From 2012 to 2023, average annual rates of growth with regard to non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses exports from Poland stood at X%. At the same time, Hungary (X%), Lithuania (X%), Russia (X%), the Czech Republic (X%), Bulgaria (X%) and Slovakia (X%) displayed positive paces of growth. Moreover, Hungary emerged as the fastest-growing exporter exported in Eastern Europe, with a CAGR of X% from 2012-2023. From 2012 to 2023, the share of Hungary, Russia and Lithuania increased by X, X and X percentage points, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses supplying countries in Eastern Europe were the Czech Republic ($X), Hungary ($X) and Poland ($X), together comprising X% of total exports.

Hungary, with a CAGR of X%, recorded the highest rates of growth with regard to the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2023, the export price in Eastern Europe amounted to $X per ton, surging by X% against the previous year. Overall, the export price recorded a pronounced expansion. The pace of growth was the most pronounced in 2020 when the export price increased by X% against the previous year. Over the period under review, the export prices attained the maximum in 2023 and is expected to retain growth in the near future.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was the Czech Republic ($X per ton), while Slovakia ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Hungary (X%), while the other leaders experienced more modest paces of growth.

Imports of Non-Antibiotic, Non-Hormone, Non-Alkaloid Medicaments For Therapeutic Or Prophylactic Uses

Imports in Eastern Europe

In 2023, overseas purchases of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses were finally on the rise to reach X tons for the first time since 2018, thus ending a four-year declining trend. Overall, imports showed a noticeable increase. The pace of growth was the most pronounced in 2018 with an increase of X% against the previous year. As a result, imports reached the peak of X tons. From 2019 to 2023, the growth of imports of remained at a somewhat lower figure.

In value terms, imports of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses surged to $X in 2023. In general, imports recorded resilient growth. As a result, imports reached the peak and are likely to continue growth in the immediate term.

Imports by Country

Hungary represented the largest importer of non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses in Eastern Europe, with the volume of imports accounting for X tons, which was near X% of total imports in 2023. Poland (X tons) held the second position in the ranking, distantly followed by Russia (X tons) and Romania (X tons). All these countries together took near X% share of total imports. The following importers - Estonia (X tons) and Bulgaria (X tons) - each amounted to a X% share of total imports.

From 2012 to 2023, the most notable rate of growth in terms of purchases, amongst the key importing countries, was attained by Hungary (with a CAGR of X%), while imports for the other leaders experienced more modest paces of growth.

In value terms, the largest non-antibiotic, non-hormone, non-alkaloid medicaments for therapeutic or prophylactic uses importing markets in Eastern Europe were Hungary ($X), Russia ($X) and Bulgaria ($X), with a combined X% share of total imports.

In terms of the main importing countries, Hungary, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in Eastern Europe stood at $X per ton in 2023, surging by X% against the previous year. Overall, the import price recorded prominent growth. The growth pace was the most rapid in 2020 an increase of X%. Over the period under review, import prices attained the maximum in 2023 and is expected to retain growth in the near future.

There were significant differences in the average prices amongst the major importing countries. In 2023, amid the top importers, the country with the highest price was Bulgaria ($X per ton), while Poland ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Estonia (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform